LONDON (Alliance News) - GlaxoSmithKline PLC is facing fresh allegations that it bribed doctors and officials in Syria to boost sales of its medicines, in the wake of recent accusations about corruption in its non-prescription business in the country, Reuters reported Tuesday.
Glaxo said on Monday it would investigate the new corruption claims, involving its own staff and local distributors. It also said it has suspended relations with its Syrian distributors pending the results of the probe.
The new accusations follow after a series of similar bribery claims made against the company in China, Iraq, Jordan, Lebanon and Poland.
http://uk.reuters.com/article/2014/08/11/uk-gsk-corruption-syria-idUKKBN0GB1PX20140811
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.